Dr Lloyd Czaplewski

Director, Abgentis Limited, Abingdon, Oxon, UK

I have been involved in antibacterial R&D for 15-years, specialising in cell divison inhibitors (Fts Z) & DNA supercoiling (GyrB/ParE).   After building up and even selling an antibacterial biotech (2001-2011), I started my own antibacterial biotech – Abgentis Limited to re-engineer aminocoumarin antibiotics.  I also consult via Chemical Biology Ventures Limited.  I have worked with MRC, BBSRC & Wellcome Trust funding previously and was a member of the BSAC Urgent Need group.

 

 

Share thisShare on FacebookTweet about this on TwitterEmail this to someone
The British Society for Antimicrobial Chemotherapy (BSAC)
© 2017 Registered Charity 1093118.

Registered as a company limited by guarantee in England & Wales No: 4443910

By using this site, you agree to using cookies.
For more details about cookies and how to disable them, see resource here >
Top